Academia.eduAcademia.edu

Figure from:Regional Governance on Covid-19 Vaccination in The Southeast Asia

See full PDFdownloadDownload figure
COVID-19 Vaccine Global Access Facility (COVAX) to ensure the country's access for its 20 million Singapore The diplomatic strategy conducted by the Philippines in obtaining a COVID-19 vaccine is through the Department of Foreign Affairs (DFA). This was conducted by supervising the involvement of foreign governments, pharmaceutical companies, and other related entities in the development, evaluation, as well as selection of vaccines for procurement and clinical trials. This ensures public accessibility towards COVID-19 Vaccines (NDVP, 2021) since they are facilitated by a program called The Philippine National Deployment and Vaccination Plan for COVID-19 Vaccines (NDVP). This program was developed by the Government under the leadership of President Rodrigo Roa Duterte, and under the guidance of Minister of Health, Franscisco T. Duque III, and Chairman of the COVID-19 Vaccine Group, Secretary Carlito G. Galvez Jr.

Figure 1 COVID-19 Vaccine Global Access Facility (COVAX) to ensure the country's access for its 20 million Singapore The diplomatic strategy conducted by the Philippines in obtaining a COVID-19 vaccine is through the Department of Foreign Affairs (DFA). This was conducted by supervising the involvement of foreign governments, pharmaceutical companies, and other related entities in the development, evaluation, as well as selection of vaccines for procurement and clinical trials. This ensures public accessibility towards COVID-19 Vaccines (NDVP, 2021) since they are facilitated by a program called The Philippine National Deployment and Vaccination Plan for COVID-19 Vaccines (NDVP). This program was developed by the Government under the leadership of President Rodrigo Roa Duterte, and under the guidance of Minister of Health, Franscisco T. Duque III, and Chairman of the COVID-19 Vaccine Group, Secretary Carlito G. Galvez Jr.

Related Figures (7)

Table 1. Vaccine Distribution in Southeast Asia Countries The general description of vaccine distribution in Southeast Asia countries is presented in the following table 1:
Table 1. Vaccine Distribution in Southeast Asia Countries The general description of vaccine distribution in Southeast Asia countries is presented in the following table 1:
Brunei
Brunei
Table 2. Timeline for Malaysia’s Vaccine Acquisition Malaysia gave conditional approval to use AstraZeneca from UK and Sinovac from China, and by early 2021, 32 million doses of Pfizer and Sinovac had been received. The approval was issued days after the launching of the national COVID-19 inoculation program on February 2, 2021. The vaccination started on February 24 using Pfizer and BioNTech to reduce the spike in cases and help the economic recovery (CNN Indonesia, 2021). The following is a strategy used by Malaysia in procuring a COVID-19 vaccine:
Table 2. Timeline for Malaysia’s Vaccine Acquisition Malaysia gave conditional approval to use AstraZeneca from UK and Sinovac from China, and by early 2021, 32 million doses of Pfizer and Sinovac had been received. The approval was issued days after the launching of the national COVID-19 inoculation program on February 2, 2021. The vaccination started on February 24 using Pfizer and BioNTech to reduce the spike in cases and help the economic recovery (CNN Indonesia, 2021). The following is a strategy used by Malaysia in procuring a COVID-19 vaccine:
The table 2 s hows the strategy of Malaysia in procuring the COVID-19 vaccines, starting from the case detection in December 2019 to bilateral and multilateral diplomatic steps. The government Vaccine Supp as ensuring ti auspices of t (JKJAV, 2021) had created a special committee named The Special Committee on COVID-19 y (JKAV) to conduct a national immunization program against the pandemic such mely access to vaccine supplies for domestic needs. The committee is under the he Minister of Health and the Minister of Science, Technology, and Innovation . The following is the vaccine data of Malaysia in February 2021:
The table 2 s hows the strategy of Malaysia in procuring the COVID-19 vaccines, starting from the case detection in December 2019 to bilateral and multilateral diplomatic steps. The government Vaccine Supp as ensuring ti auspices of t (JKJAV, 2021) had created a special committee named The Special Committee on COVID-19 y (JKAV) to conduct a national immunization program against the pandemic such mely access to vaccine supplies for domestic needs. The committee is under the he Minister of Health and the Minister of Science, Technology, and Innovation . The following is the vaccine data of Malaysia in February 2021:
Table 3. Supply of COVID-19 Vaccines Acquired by Malaysia
Table 3. Supply of COVID-19 Vaccines Acquired by Malaysia
Source: mClinica, 2020 Table 5. ASEAN Member Countries that Produce COVID-19 Vaccines Four countries in ASEAN produce COVID-19 vaccines as presented in the following table 5:
Source: mClinica, 2020 Table 5. ASEAN Member Countries that Produce COVID-19 Vaccines Four countries in ASEAN produce COVID-19 vaccines as presented in the following table 5:
Source: Delegation of the European Union to ASEAN, 2021 Table 6. Vaccine Doses in ASEAN
Source: Delegation of the European Union to ASEAN, 2021 Table 6. Vaccine Doses in ASEAN